References

  1. European Centre for Disease Prevention and Control. "Factsheet for experts". 2014. Google Scholar

  2. Center for Disease Dynamics Economics & Policy. State of the World's Antibiotics, 2015. CDDEP: Washington, DC 2015. Google Scholar

  3. "Antimicrobial resistance. Global report on surveillance". The World Health Organization. April 2014. ISBN 978 92 4 156474 8. Google Scholar

  4. Centers for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States. Atlanta. 2013. Google Scholar

  5. Kayange Neema, Kamugisha Erasmus, Mwizamholya Damas L, Jeremiah Seni, Mshana Stephen E. Predictors of Positive Blood Culture and Deaths Among Neonates with Suspected Neonatal Sepsis in a Tertiary Hospital, Mwanza-Tanzania. BMC Pediatrics. 2010; 10: 39. PubMed | Google Scholar

  6. Roca Anna, Quinto Llorenc, Abacassamo Fatima, Morais Luis, Valles Xavi, Espasa Mateu, Sigau'que Betuel, Sacarlal Jahit, Macete Eusebio, Nhacolo Ariel, Mandomando Inacio, Levine Myron, Alonso Pedro. Invasive Haemophilus influenza Disease in Children Less than 5 Years of Age in Manhiça, a Rural area of Southern Mozambique. Trop Med Int Health. 2008; 13(6): 818-26. Google Scholar

  7. Isenalumehe Anthony E, Oviawe Osawaru. Polypharmacy Its Cost Burden and Barrier to Medical Care in a Drug Oriented Health Care System. Int J Health Serv. 1988; 18(2): 335-342. Google Scholar

  8. World Health Organization. How to Investigate Drug Use in Health Facilities. Selected Drug Use Indicators, Geneva, World Health. 1993. Google Scholar

  9. Hogerzeil HV, Bimo, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, Azad Chowdhury AK, Das AM, Kafle KK, Mabedeje AFB, Massele AY. Field tests for rational drug use in twelve developing countries. Lancet. 1993; 342(8884): 1408-10. PubMed | Google Scholar

  10. Bronzwaer Stef LAM, Cars Otto, Buchholz Udo, Mölstad Sigvard, Goettsch Wim, Veldhuijzen Irene K, Kool Jacob L, Sprenger Marc JW, Degener John E. The relationship between antimicrobial use and antimicrobial resistance in Europe. Emerg Infect Dis. 2002; 8(3): 278-282. Google Scholar

  11. Ghana National Drugs Programme (GNDP), Standard Treatment Guidelines. 6th Edition. Ministry Of Health. 2010. Google Scholar

  12. Ahiabu Mary-Anne, Tersbol Britt P, Biritwum Richard, Bygbjerg Ib C, Magnussen Pascal. A retrospective audit of antibiotic prescriptions in primary health-care facilities in Eastern Region, Ghana. Health Policy Plan. 2016; 31(2): 250-8. PubMed | Google Scholar

  13. Bosu WK, Ofori-Adjei D. An audit of prescribing practices in Health Care Facilities of the Wassa West District of Ghana. West AfrJ Med. 2000; 19(4): 298-303. PubMed | Google Scholar

  14. Arhinful Kojo Daniel. WHO Pharmaceutical Situation Assessment-Level II-Health Facilities Survey in GHANA. Report of a survey conducted May-June 2008. JUNE 2009. Google Scholar

  15. Abula Teferra, Desta Zeruesenay, Yohannes Asfawossen G. Prescribing Pattern of Drugs in Medical Wards of Three Hospitals in North-West Ethiopia. J Ethiopia Med Pract. 2002; 4(1): 8-13. Google Scholar

  16. Akande TM, Oloye MO. Prescription Pattern at a Secondary Health Care Facility in Ilorin, Nigeria. Ann Afr Med. 2007; 6(4): 186-189. PubMed | Google Scholar

  17. Tukson JT, Cobbold C, Incoom R. Explorative assessment of prescribing pattern at Cape Coast Teaching Hospital. Accessed on 10/7/17.

  18. Afriyie Enock Owusu, Edusei Anthony Kwaku, Mensah Kofi Akohene, Nkoom Bernard, Okyere Paul, Adjei Odotei, Appiah-Brempong Emmanual. Antibiotics availability and usage in health facilities: a case of the offinso-south municipality of Ghana. J Biol Agric Healthc. 2015; 5(2): 139-144. Google Scholar

  19. Harvard Medical School and Harvard Pilgrim Health, World Health Organization. Using indicators to measure country pharmaceutical situations Fact Book on WHO Level I and Level II monitoring indicators, edn. Geneva: World Health Organization. 2006. Google Scholar

  20. Dumoulin Jérôme, Kaddar Miloud, Velásquez Germán. Guide to drug financing mechanisms. Geneva. World Health Organization. 1998. Google Scholar

  21. Afriyie Daniel, Tetteh Raymond. A description of the pattern of rational drug use in Ghana Police Hospital. International Journal of Pharmacy and Pharmacology. 2014; 3(1): 143-148. Google Scholar

  22. Ofori-Asenso Richard, Brhlikova Petra, Pollock Allyson M. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015). BMC Public Health. 2016; 16: 724. PubMed | Google Scholar

  23. Ghana Statistical Service (GSS), Ghana Health Service (GHS) and ICF International, 2015. Ghana Demographic and Health Survey 2014. Rockville, Maryland, USA: GSS, GHS and ICF International. Google Scholar

  24. Ibrahim MTO. Physicians Prescribing Behaviour in Two Tertiary Health Care Facilities in North Western Nigeria. Sahel Med J. 2004; 7(4): 114-118. Google Scholar

  25. Shah Sital. Aga Khan University Hospital promotes rational medicines use through pharmacy and therapeutics committee. Opportunities and challenges in hospital pharmacy practice in Kenya. 2007. Google Scholar

  26. Llor Carl, Bjerrum Lars. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014; 5(6): 229-241. PubMed | Google Scholar

  27. Mayo Clinic. Antibiotics: misuse puts you and others at risk. Accessed on 10/8/17.

  28. Polage CR, Bedu-Addo G, Owusu-Ofori A, Frimpong E, Lloyd W, Zurcher E et al. Laboratory use in Ghana: physician perception and practice. Am J Trop Med Hyg. 2006; 75(3): 526-31. PubMed | Google Scholar

  29. Ministry of Health/Zimbabwe Essential Drugs Action Programme. Essential Drugs Survey. In How to investigate drug use in health facilities, WHO: Geneva; 1993, 74(WHO/DAP/93.1). Google Scholar

  30. Christensen RF. A strategy for the improvement of prescribing and drug use in rural health facilities in Uganda. Ugandan Essential drugs and management program; 2 September-11 October 1990: in how to investigate drug use in health facilities. Geneva: WHO; 1993.74(WHO/DAP/93.1). Google Scholar

  31. Ghimire Saurav, Nepal Sushil, Bhandari Sushil, Nepal Prabha, Palaian Subish. Prospective surveillance of drug prescribing and dispensing in a teaching hospital in Western Nepal J Pak Med Assoc. 2009; 59(10): 726-31. Google Scholar

  32. GNDP. A Baseline Survey of the Pharmaceutical Sector. Ghana National Drug Program, Accra. 2004. Google Scholar

  33. Uzochukwu Benjamin, Onwujekwe Obinna , Akpala Cyril. Effect of the Bamako-Initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria. Health Policy Plan. 2002; 17(4): 378-83. PubMed | Google Scholar

  34. Fleming-Dutra Katherine E, Hersh Adam L, Shapiro Daniel J, Bartoces Monica, Enns Eva A, File Thomas M Jr, Finkelstein Jonathan A, Gerber Jeffrey S, Hyun David Y, Linder Jeffrey A, Lynfield Ruth, Margolis David J, May Larissa S, Merenstein Daniel, Metlay Joshua P, Newland Jason G, Piccirillo Jay F, Roberts Rebecca M, Sanchez Guillermo V, Suda Katie J, Thomas Ann, Woo Teri Moser, Zetts Rachel M, Hicks Lauri A. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. Journal of the American Medical Association. 2016; 315(17): 1864-1873. PubMed | Google Scholar